Nabiha Saklayen


Nabiha Saklayen is the CEO and cofounder of Cellino, where she works to personalize both cells and medicine.Nabiha Saklayen's team is building the first closed-loop system to make custom cell therapies accessible to every human for diseases such as Parkinson's, diabetes and vision loss. She was selected as a "Pioneer" in MIT Tech Review's "35 Innovators under 35" list for her patented invention in cellular laser editing and was a 2019 Forbes "30 under 30" awardee for health care. She received her PhD in physics from Harvard University as a Howard Hughes Medical

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved